The Stanford-StartX Fund-backed NFT marketplace operator has now secured more than $27m in funding altogether.

Smile Invest and Innovation Industries Fund have co-led a $37m first tranche for TUe spinout Effect Photonics’ series C round.

IBM Ventures participated in a $20m round for the neurological disease diagnostics technology spinout of Tel Aviv University.

Cybrexa has secured $25m to progress a cancer treatment based on research at Yale University and University of Rhode Island.

The immuno-oncology company, based on University of Turin research, has completed a $21m series B round led by Claris Ventures.

Oxford Sciences Innovation has returned to back a $30m funding round for Genomics, having previously contributed to a 2018 series B round.

IP Group and V-Bio have backed a round that will support phase 2 trials for a treatment for diabetic macular edema.

Symbio Robotics has received cash from the UC Berkeley-linked House Fund as it announces its official company launch.

The MIT and Harvard-linked contract management platform developer has taken its total funding to more than $55m.